Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
[Treatment of spasticity in children with cerebral palsy with botulinum toxin A]
Ea Serie Lundegaard Madsen1, Stig Sonne-Holm, Christian Wong
1Ortopædkirurgisk Afdeling, Hvidovre Hospital, Kettegård Alle 30, 2650 Hvidovre. jesper.bencke@regionh.dk.
Abstract:
Over the latest 30 years there has been an increasing use of botulinum toxin A injections in the lower limbs in children with cerebral palsy. However, the conclusions regarding effect of treatment in both randomized controlled and non-controlled trials have been inconclusive. One explanation may be that children with cerebral palsy do not always exhibit pure spasticity and/or dystonia of the affected muscles. Furthermore, the dose, injection volume and injection technique may vary from study to study. The evidence for the effect is so small that careful consideration on whether to continue this treatment regimen or not is needed.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Alterations in Muscle Tone ll

